Provided by Tiger Trade Technology Pte. Ltd.

Apogee Therapeutics

62.24
+0.11000.18%
Post-market: 62.240.00000.00%18:51 EST
Volume:1.37M
Turnover:85.45M
Market Cap:4.25B
PE:-14.27
High:64.95
Open:64.45
Low:61.75
Close:62.13
52wk High:84.56
52wk Low:26.20
Shares:68.32M
Float Shares:47.47M
Volume Ratio:1.31
T/O Rate:2.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3614
EPS(LYR):-3.3001
ROE:-38.41%
ROA:-25.26%
PB:7.25
PE(LYR):-18.86

Loading ...

Apogee Therapeutics Chief Medical Officer Carl Dambkowski Reports Disposal of Common Shares

Reuters
·
Feb 05

Apogee Therapeutics CFO Jane Henderson Reports Sale of Common Shares

Reuters
·
Feb 05

BTIG Sticks to Its Buy Rating for Apogee Therapeutics (APGE)

TIPRANKS
·
Feb 03

Apogee Therapeutics Inc : Jefferies Cuts Target Price to $95 From $98

THOMSON REUTERS
·
Feb 02

13D Filings -- Barrons.com

Dow Jones
·
Jan 31

Analysts Are Bullish on These Healthcare Stocks: Concentra Group Holdings Parent, Inc. (CON), Apogee Therapeutics (APGE)

TIPRANKS
·
Jan 31

Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), GE Healthcare Technologies Inc (GEHC) and Apogee Therapeutics (APGE)

TIPRANKS
·
Jan 31

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Sanofi (OtherSNYNF)

TIPRANKS
·
Jan 26

Apogee selloff on Sanofi data brings opportunity, says UBS

TIPRANKS
·
Jan 26

Apogee Therapeutics selloff on Sanofi data overdone, says Citi

TIPRANKS
·
Jan 25

Apogee Therapeutics Falls on Investor Sells Shares Worth $133.5M

Dow Jones
·
Jan 24

Fairmount Funds Management Reports Disposal of Apogee Therapeutics Common Shares

Reuters
·
Jan 23

Apogee Therapeutics' Lead Drug Shows Promise, but Valuation has Reached Near-Term Peak, RBC Says

MT Newswires Live
·
Jan 22

Apogee Therapeutics Cut to Sector Perform From Outperform by RBC Capital

Dow Jones
·
Jan 22

RBC Downgrades Apogee Therapeutics to Sector Perform From Outperform, Raises Price Target to $83 From $70, Keeps Speculative Risk

MT Newswires Live
·
Jan 22

Apogee Therapeutics downgraded to Sector Perform from Outperform at RBC Capital

TIPRANKS
·
Jan 22

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and GoodRx Holdings (GDRX)

TIPRANKS
·
Jan 19

Apogee Therapeutics CEO Michael Thomas Henderson Reports Disposal of Common Shares

Reuters
·
Jan 17

Funding for Risky Biotechs Is Returning -- WSJ

Dow Jones
·
Jan 13

Apogee Therapeutics Chief Medical Officer Carl Dambkowski Reports Disposal of Common Shares

Reuters
·
Jan 10